Genmab — November 2016
-
Præcis HLF!
Og så bare godt med bull på den hvis man synes 30% er for lavt 
-
Novod filer lidt af kursen men er fortsat meget positiv "We maintain Buy but cut our target price to DKK 1,550 (1,585),
due to higher costs and a shift of milestones between years. We view it
as positive that Genmab is investing to build an even stronger company." -
Jeg samler også op på Børsen Play omkring kl. 10.
-
Jeg har desværre kun et par minutter.
-
Det lyder som om der ska komme voldsomme gode nyhder for at trække kursen bare lidt op? og efterfølgeden falder den tilbage, lige som ved det fantastiske regnskab. forstår ik helt hvorfor den ryger frem og tilbage i samme leje, som den har gjort siden maj?
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind